Adderall Xr

Overview Forums Topics Doctor Questions
Ask our Community
Members
Doctor Answers
Dr. Nikola Gjuzelov
Dr. Nikola Gjuzelov / Schizophrenia
Dr. Nikola Gjuzelov
Dr. Nikola Gjuzelov / ADD and ADHD
Dr. Nikola Gjuzelov
Dr. Nikola Gjuzelov / Sexual Health - Women
More
Related Searches
News
Shire's Quarterly Revenues Grow by 25% to $1 Billion for the First Time
DUBLIN, July 28, 2011 /PRNewswire/ --   Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces results for the three months to June 30, 2011. Financial Highlights Q2 2011(1) Product sales
Shire´s Quarterly Revenues Grow by 25% to $1 Billion for the First Time
DUBLIN, July 28, 2011 /PRNewswire/ Shire plc , the global specialty biopharmaceutical company, announces results for the three months to June 30, 2011. Financial Highlights Q2 2011(1) Product sales $993 million +30% Total revenues $1,063 …
Impax Labs 2nd-quarter profit sinks 60 percent
Impax Laboratories Inc. said Tuesday its second-quarter earnings sank 60 percent compared to last year's quarter, when the drugmaker had marketing exclusivity to sell a generic version of the enlarged prostate treatment Flomax.
Impax Laboratories Reports Second Quarter 2011 Financial Results
HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) today reported second quarter ended June 30, 2011 financial results. “Our second quarter 2011 revenues and earnings were lower than the prior year period primarily due to higher s
Press Release
Impax Laboratories Inc. Posted on:02 Aug 11 Impax Laboratories, Inc. (NASDAQ: IPXL) today reported second quarter ended June 30, 2011 financial results.